AcquisitionOther
COLLEGIUM PHARMACEUTICAL, INC acquired BioDelivery Sciences Broadening Pain Portfolio
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
COLLEGIUM PHARMACEUTICAL, INC -> BioDelivery Sciences Broadening Pain Portfolio · $75 Million
BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions.
Open source record (SEC) ↗